Fibrosis inhibitor for implanted organ

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/22 (2006.01) A61K 48/00 (2006.01) A61P 9/00 (2006.01) A61P 37/06 (2006.01) A61P 43/00 (2006.01) C07K 14/475 (2006.01) C12N 15/09 (2006.01)

Patent

CA 2594629

A pharmaceutical preparation comprising a hepatocellular growth factor, or DNA coding for the same, or the like is capable of inhibiting any fibrosis of implanted organ after organ transplantation. The pharmaceutical preparation is useful in the field of organ transplantation and the field of regeneration medicine.

La présente invention concerne une préparation pharmaceutique contenant un facteur de croissance hépatocellulaire, ou codage ADN pour ledit facteur, lequel peut inhiber toute fibrose de l~organe implanté après une transplantation d~organe. La préparation pharmaceutique est utile dans le domaine de la transplantation d'organes et de la médecine de régénération.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Fibrosis inhibitor for implanted organ does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fibrosis inhibitor for implanted organ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrosis inhibitor for implanted organ will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1627583

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.